Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
A prospective study assessing gastric cancer screening using fecal multi-target DNA analysis, currently RECRUITING.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, and preliminary efficacy of XH001 injection combined with a neoantigen vacc…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial [NA]
This clinical trial evaluates whether eradicating Helicobacter pylori subtypes reduces gastric cancer risk in high-risk individuals using a …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection
The document reports a prospective gastric cancer screening trial that uses detection of Helicobacter pylori high-risk SNPs, and it is curre…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
This is an observational clinical trial from Fudan University studying gastric cancer in people with high-risk Helicobacter pylori infection…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) [Phase 2]
Phase 2 clinical trial update on Givastomig combined with nivolumab and chemotherapy for CLDN18.2-positive metastatic gastric cancer; the st…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer
This clinical trial update evaluates the efficacy and survival outcomes of perioperative treatment for locally advanced gastric or gastroeso…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of AZD5863 in adults with advanced or metastatic solid tumors is currently recruiting, including gastric cancer, gastroeso…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Q702, an oral Axl/Mer/CSF1R tyrosine kinase inhibitor, in combination with pembrolizumab, for selected advanced…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery
Clinical trial update describing an early recovery after surgery protocol aimed at improving quality of life for participants with stage 0 t…
-
EMA approval · 2026-02-23EMA Authorised: Ogivri (trastuzumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Ogivri, a trastuzumab biosimilar from Biosimilar Collaborations Ireland Limited, for gastric cancer and breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering [Phase 1, Phase 2]
A Phase 1/2 study evaluating autologous tumor-infiltrating lymphocytes edited by CRISPR to inhibit CISH for metastatic gastrointestinal canc…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer [Phase 2]
Phase 2 trial comparing total neoadjuvant chemotherapy with the FLOT regimen versus standard perioperative FLOT in gastric and gastroesophag…
-
CLINICAL_TRIALS other · 2026-02-23Clinical Trial Update: Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03) [Phase 2]
Clinical trial update for the DESTINY-Gastric03 study, a Phase 1b/2 investigation of trastuzumab deruxtecan (T-DXd) combinations in advanced…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Completed clinical trial evaluating frailty scales to predict chemotherapy toxicity in older adults with gastrointestinal cancers.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]
Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes [NA]
Cedars-Sinai Medical Center is recruiting for a study evaluating virtual reality to manage gastrointestinal cancer pain and improve patient-…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
AZD5305 is being evaluated as a monotherapy and in combination with anti-cancer agents in a Phase 1/2 trial for multiple advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination [Phase 1, Phase 2]
Phase 1/2 trial update evaluating MCLA-129, a bispecific anti-EGFR and anti-c-MET antibody, in advanced non-small cell lung cancer and other…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Laparoscopic Versus Open Gastrectomy for Gastric Cancer [NA]
A clinical trial comparing laparoscopic versus open gastrectomy for gastric cancer has completed enrollment. The update notes status as comp…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for PF-07265028 as a single agent and in combination with sasanlimab in advanced/metastatic solid tumors has b…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression [Phase 3]
Phase 3 trial evaluating bemarituzumab plus chemotherapy versus placebo plus chemotherapy in FGFR2b-overexpressing gastric and gastroesophag…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment [NA]
Clinical trial update on molecular analysis for gastro-esophageal cancer using a multicenter discrete choice experiment; the study is curren…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1 [Phase 4]
Phase 4 clinical trial update describing Helicobacter pylori screening and treatment in an at-risk South Florida community (AIM 1).
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of MRG007 (ARR-217) in patients with advanced solid tumors is recruiting, evaluating safety and initial efficacy signals in …